The deal size was increased to $200M in common stock from $175M in common stock. Jefferies, JPMorgan, BofA and SVB Securities acted as joint book running managers for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TVTX:
- Travere Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
- Travere Therapeutics initiated with a Buy, $37 price target at Guggenheim
- Travere Therapeutics initiated with a Buy at Guggenheim
- Travere Therapeutics price target lowered to $42 from $44 at Canaccord
- Travere Therapeutics announces $175M common stock offering
